Related Experiment Video
Updated: Apr 12, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Airway microbiota and acute respiratory infection in children
Kohei Hasegawa1, Carlos A Camargo
1From the Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Insights
The airway microbiota influences infant respiratory infection risk and severity. Modulating these microbes may optimize immunity and reduce hospitalizations in children.
Area of Science:
- Pediatric medicine
- Microbiology
- Immunology
Background:
- Acute respiratory infections (ARIs) are a primary cause of infant hospitalization in the US.
- Traditional risk factors do not fully explain variations in ARI incidence and severity among children.
- Molecular diagnostics reveal the significant role of the human microbiota in immune system development.
Discussion:
- A 'risk and resilience' model is proposed, linking airway microbiota composition to ARI outcomes.
- Specific 'risk microbiota' may increase ARI incidence/severity, while 'resilience microbiota' may decrease them.
- Airway microbiota composition is a key, yet under-explored, factor in pediatric respiratory health.
Key Insights:
- Airway microbiota composition is associated with increased or decreased risk and severity of ARIs in children.
- The 'risk and resilience' model provides a framework for understanding host-microbe interactions in pediatric respiratory infections.
- Early childhood is a critical window for potentially modulating airway microbiota.
Outlook:
- Targeting and modulating airway microbiota presents a novel therapeutic strategy for preventing and treating pediatric ARIs.
- Further research into specific microbial signatures and their functional roles is warranted.
- Optimizing airway immunity through microbiota modulation could significantly reduce infant hospitalizations due to respiratory infections.
Abstract:
Acute respiratory infections (ARIs), such as bronchiolitis and pneumonia, are the leading cause of hospitalization of infants in the US. While the incidence and severity of ARI can vary widely among children, the reasons for these differences are not fully explained by traditional risk factors (e.g., prematurity, viral pathogens). The recent advent of molecular diagnostic techniques has revealed the presence of highly functional communities of microbes inhabiting the human body (i.e., microbiota) that appear to influence development of local and systemic immune response. We propose a 'risk and resilience' model in which airway microbiota are associated with an increased (risk microbiota) or decreased (resilience microbiota) incidence and severity of ARI in children. We also propose that modulating airway microbiota (e.g., from risk to resilience microbiota) during early childhood will optimize airway immunity and, thereby, decrease ARI incidence and severity in children.
More Related Videos
Related Concept Videos
Microbiota of the Respiratory Tract
Development of the Oral Microbiota
Development of Human Microbiota
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
The Oral Microbiota

